Effect of an integrated community-based intervention on antenatal care, incidence of malaria in pregnancy, adverse pregnancy and birth outcomes in rural Mali and Burkina Faso: The INTEGRATION cluster randomized trial.

A secondary analysis of the INTEGRATION cluster randomized trial in rural Mali and Burkina Faso found that a four-month community-based intervention delivering intermittent preventive treatment for malaria during seasonal home visits did not significantly improve antenatal care coverage, reduce malaria incidence in pregnancy, or improve adverse pregnancy and birth outcomes compared to standard clinic-based care.

The Gist

Imagine a village where the roads are rough, the clinics are far away, and many pregnant women struggle to get the medical care they need. In these villages in Mali and Burkina Faso, malaria is a constant threat, like a shadow that follows a pregnant woman, risking the health of both her and her baby.

Doctors and health organizations have a rulebook: pregnant women should visit the clinic at least eight times to get checks and medicine. One specific medicine, a pill called IPTp-SP, is like a shield against malaria. But getting these pills is hard because women often can't make it to the clinic.

The Big Experiment: The "Community Delivery" Idea

The researchers behind this study, called the INTEGRATION project, had a clever idea. They knew that in these same villages, health workers were already going door-to-door during the rainy season to give malaria medicine to children.

They thought: "Why not use that same delivery truck to drop off medicine for pregnant women too?"

So, they set up a massive experiment. They picked 40 different villages (20 in Mali, 20 in Burkina Faso) and split them into two teams:

1. The Control Team: These villages did things the usual way. Pregnant women had to walk to the clinic to get their malaria pills.
2. The Intervention Team: In these villages, for four months out of the year, health workers visited pregnant women at their homes to give them the malaria pills and remind them to see a doctor.

The Goal
The researchers hoped this "home delivery" service would do three things:

• The Bus Stop Effect: Get more women to visit the clinic (because the health workers would tell them, "Hey, you need to see the doctor!").
• The Shield Effect: Stop malaria from attacking pregnant women.
• The Safety Net Effect: Reduce bad outcomes like premature babies, low birth weight, or sadly, the death of the mother or baby.

What Actually Happened? (The Plot Twist)

After two years of watching and collecting data from thousands of women, the researchers found a surprising result: The home delivery service didn't change the outcome.

Here is the breakdown in simple terms:

• Did more women go to the clinic? No. Even though health workers visited them at home, the number of women going to the clinic didn't go up significantly compared to the villages where they didn't get home visits.
  • Analogy: Imagine a bus driver stopping at your house to tell you, "The bus is coming, get on!" But you still didn't get on the bus. Maybe you were too tired, or the bus schedule didn't work for you, or you just didn't think it was necessary. The "nudge" wasn't strong enough to change behavior.
• Did malaria go down? No. The number of pregnant women getting malaria was roughly the same in both groups.
  • Analogy: It's like putting a small umbrella over a few people during a storm. It didn't stop the rain from soaking everyone else, and the people under the umbrella didn't stay dry enough to make a difference in the overall storm.
• Did babies and mothers stay safer? No. The rates of premature births, low birth weight, and other complications were the same in both groups.

Why Didn't It Work?

The researchers had a few theories about why the "home delivery" idea didn't pan out:

1. It was too short: The home visits only happened for four months a year, for two years. Changing deep-rooted habits (like walking miles to a clinic) takes a long time. It's like trying to learn a new language by studying for only one hour a week; you won't become fluent.
2. The "Clinic" vs. "Home" confusion: In the villages where they visited homes, the health workers gave the medicine but didn't necessarily count that visit as a "clinic visit." So, the official numbers for "clinic visits" didn't go up, even though women were getting care.
3. Other things were happening: In Burkina Faso, the government was already doing a lot of work to improve healthcare (building more clinics, hiring more nurses). This made the whole country better, so the specific experiment didn't stand out as the "hero." In Mali, the problems were so deep (very poor roads, very few doctors) that a four-month project couldn't fix them.

The Takeaway

This study is like a lesson in patience and scale. The idea of bringing healthcare to people's doorsteps is a good one, and it feels like it should work. But in the real world, fixing complex health problems is like trying to fill a giant bathtub with a teaspoon. You need a bigger bucket (more resources) and you need to keep pouring for a longer time (a longer duration) to see the water level rise.

The researchers concluded that while this specific four-month project didn't work, we shouldn't give up on the idea. Instead, we need to try it for a whole year, or even longer, and combine it with other improvements to the health system to truly make a difference for mothers and babies in these rural areas.

Technical Summary

1. Problem Statement

Despite World Health Organization (WHO) recommendations for at least eight antenatal care (ANC) contacts per pregnancy, coverage remains low in sub-Saharan Africa. Low ANC attendance is directly linked to inadequate uptake of Intermittent Preventive Treatment in pregnancy with Sulfadoxine-Pyrimethamine (IPTp-SP), a critical intervention for preventing malaria in pregnancy (MiP). Low IPTp-SP coverage is associated with severe adverse outcomes, including low birth weight, prematurity, stillbirth, and maternal death.

In rural Mali and Burkina Faso, barriers such as remoteness, poor infrastructure, and financial constraints hinder access to health facilities. While Seasonal Malaria Chemoprevention (SMC) is successfully used to deliver antimalarials to children (3–59 months) via community health workers (CHWs), this delivery channel has not been fully leveraged for pregnant women. The study aimed to determine if integrating IPTp-SP delivery into the existing SMC home-visit platform could improve ANC coverage, reduce MiP incidence, and mitigate adverse pregnancy outcomes.

2. Methodology

• Study Design: A secondary analysis of data from the INTEGRATION cluster randomized trial.
• Setting: 40 health facility clusters (20 in Boussé, Burkina Faso; 20 in Kangaba, Mali) located in seasonal malaria transmission zones.
• Intervention:
  • Intervention Arm: During the high-transmission season (July–October) for two consecutive years (2022–2023), CHWs conducting SMC home visits identified pregnant women. Those who had initiated ANC and received a dose of IPTp-SP at least 28 days prior received a subsequent dose at home. Women not yet in ANC or with symptoms were referred to facilities. All women received counseling on ANC importance.
  • Control Arm: Standard of care where IPTp-SP was administered only at health facilities during routine ANC visits.
• Data Sources & Period:
  • Pre-intervention: January 2020 – June 2022.
  • Post-intervention: July 2022 – April 2024.
  • Data were extracted from ANC/delivery registers and District Health Information Software (DHIS2).
• Primary Outcomes:
  1. ANC4+ Coverage: Proportion of women attending $\ge$4 ANC visits.
  2. Adverse Pregnancy/Birth Outcomes: A composite variable including prematurity, low birth weight, stillbirth, and maternal death.
  3. Cumulative Incidence of Malaria in Pregnancy: Malaria cases per 1,000 pregnant women.
• Statistical Analysis: A Difference-in-Differences (DiD) model was used to estimate the intervention effect at the cluster level, adjusting for age and parity. The model compared changes over time between the intervention and control arms.

3. Key Contributions

• Novel Integration Strategy: This study evaluates a specific implementation strategy of leveraging the established SMC delivery platform (typically for children) to reach pregnant women with IPTp-SP and ANC counseling in rural West Africa.
• Rigorous Evaluation: It provides a robust, cluster-randomized evaluation of this integration, addressing a gap in evidence regarding whether community-based delivery of IPTp-SP complements or potentially undermines facility-based ANC attendance.
• Contextual Insights: The study highlights the disparity in baseline health system performance between the two countries (Burkina Faso had higher baseline ANC coverage than Mali) and how these factors influence intervention efficacy.

4. Results

The study included 11,199 women in Burkina Faso and 35,351 women in Mali.

• ANC4+ Coverage:
  • Burkina Faso: Baseline coverage increased from 65% to 76% over the study period. The intervention showed no statistically significant effect on ANC4+ coverage compared to the control (Adjusted DiD: -2.60; 95% CI: -13.40 to 8.20).
  • Mali: Baseline coverage remained low and stable (~16%). The intervention showed no statistically significant effect (Adjusted DiD: -2.72; 95% CI: -14.35 to 8.91).
• Adverse Pregnancy/Birth Outcomes:
  • No statistically significant difference was found between arms in either country.
  • Burkina Faso: Adjusted DiD: -0.19 (95% CI: -4.38 to 6.59).
  • Mali: Adjusted DiD: -0.36 (95% CI: -8.61 to 7.89).
• Malaria Incidence in Pregnancy:
  • Burkina Faso: Incidence increased in both arms; the intervention arm showed a non-significant increase relative to control (Adjusted DiD: +125.56; 95% CI: -389 to 640).
  • Mali: Incidence decreased in both arms; the intervention arm showed a non-significant decrease relative to control (Adjusted DiD: -12.68; 95% CI: -221 to 196).

Conclusion of Results: The four-month community-based intervention did not yield statistically significant improvements in ANC coverage, adverse outcomes, or malaria incidence compared to standard care.

5. Significance and Discussion

• Duration Limitation: The authors suggest the short duration of the intervention (4 months/year for 2 years) may have been insufficient to alter long-term health behaviors or overcome systemic barriers, especially compared to longer interventions (e.g., 12–17 months) in Kenya and Ethiopia that showed positive results.
• Health System Context: In Burkina Faso, national initiatives (free healthcare, increased staffing) likely drove the general increase in ANC coverage, masking any specific effect of the trial intervention. In Mali, persistent structural barriers (distance to facilities, low staffing density) may have prevented the intervention from gaining traction.
• Measurement Nuance: The study noted that home visits by CHWs were not counted as ANC visits in the local context (as WHO 8-contact guidelines were not yet fully implemented locally). Had these visits been counted, the intervention might have shown a positive effect on "contact" metrics.
• Implications: While the specific short-term integration strategy failed to show immediate impact, the study supports the potential of community platforms for maternal health if implemented over longer periods (e.g., full-year cycles) and integrated with broader health system strengthening. It underscores that community interventions alone may not be sufficient without concurrent improvements in facility access and quality of care.

Final Verdict: The INTEGRATION trial provides critical evidence that a short-term, seasonal integration of IPTp-SP delivery into SMC rounds did not significantly improve maternal and child health outcomes in rural Mali and Burkina Faso, suggesting that longer-duration, multi-faceted strategies are required to achieve meaningful change in these settings.